Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

347
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347
Tumor Immunotherapy01:27

Tumor Immunotherapy

493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
Cancer Therapies02:49

Cancer Therapies

7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Children's Health: 2025 and Beyond.

Delaware journal of public health·2026
Same author

Hepatitis B Birth Dose.

Delaware journal of public health·2026
Same author

The Fifth Croatia Stuttering Symposium: Part I. Treatments for early stuttering.

Journal of fluency disorders·2023
Same author

Clinical Practice Guideline by the Pediatric Infectious Diseases Society (PIDS) and the Infectious Diseases Society of America (IDSA): 2023 Guideline on Diagnosis and Management of Acute Bacterial Arthritis in Pediatrics.

Journal of the Pediatric Infectious Diseases Society·2023
Same author

Use of artificial intelligence for the diagnosis of cholesteatoma.

Laryngoscope investigative otolaryngology·2023
Same author

Vaccines for COVID-19.

Delaware journal of public health·2022
Same journal

Promoting Healthier Communities Through the Delaware State Health Improvement Plan.

Delaware journal of public health·2026
Same journal

Virtual Nurse-Led Patient Education: A Public Health Opportunity.

Delaware journal of public health·2026
Same journal

Challenges Impacting Delaware Dental Professionals' Capacity to Care for Patients with Disabilities.

Delaware journal of public health·2026
Same journal

20 Years of the Delaware Healthy Mother & Infant Consortium: Embracing the Celebration, Heeding the Call to Action.

Delaware journal of public health·2026
Same journal

Interprofessional Collaboration in the Obstetrical Emergency Department: Enhances Nursing Job Satisfaction While Improving Care of the Laboring Patient.

Delaware journal of public health·2026
Same journal

AI for Good: Utilizing Machine Learning Tools to Navigate Late Onset Neonatal Sepsis.

Delaware journal of public health·2026
See all related articles

Related Experiment Video

Updated: Jun 14, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.4K

Vaccines: An Emerging Multi-Modal Tool in the Fight Against Cancer.

Valerie Lim1, Stephen C Eppes1

  • 1ChristianaCare Health System.

Delaware Journal of Public Health
|August 30, 2024
PubMed
Summary
This summary is machine-generated.

Vaccines like the human papillomavirus (HPV) and hepatitis B virus (HBV) vaccines are crucial for preventing infectious diseases and associated adult-onset cancers. Continued research and public health efforts can further improve cancer prevention strategies.

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.4K
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

306

Related Experiment Videos

Last Updated: Jun 14, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.4K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.4K
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

306

Area of Science:

  • Oncology
  • Immunology
  • Public Health

Background:

  • Vaccines are integral to both cancer prevention and emerging cancer therapeutics.
  • Specific vaccines, such as those for HPV and HBV, target preventable risk factors for certain cancers.
  • Current vaccination practices and anti-cancer therapies have advanced significantly.

Purpose of the Study:

  • To explore the current understanding of vaccines in preventing cancer risk factors.
  • To review existing anti-cancer vaccines utilized in clinical practice.
  • To identify areas for improvement in vaccination strategies and cancer therapeutics based on CDC data.

Main Methods:

  • Review of current scientific literature on vaccine efficacy in cancer prevention.
  • Analysis of data on the application of anti-cancer vaccines in practice.
  • Examination of Centers for Disease Control and Prevention (CDC) data to assess current trends and identify gaps.

Main Results:

  • Routine childhood vaccination against HPV and HBV is effective in preventing infectious diseases.
  • These vaccinations also demonstrate efficacy in preventing subsequent adult-onset cancers.
  • Analysis indicates opportunities for enhancing current vaccination programs and therapeutic approaches.

Conclusions:

  • HPV and HBV vaccinations are vital public health tools for infectious disease and cancer prevention.
  • The role of vaccines in cancer management is expanding, with ongoing advancements in therapeutics.
  • Further improvements in vaccination coverage and therapeutic strategies are necessary for optimal cancer control.